Comparative statistics by cancer site (ICD-10)

ICD-10: Comparative statistics by registry

Table 4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group


Click on country-registry for comparison

FlagCountry-registryRegistration periodNo. of casesMaleFemaleNumber of cases by age groupRelative survival by age group
5-year survival5-year survival
No.AbsRelNo.AbsRel<4545-5455-6465-7475+<4545-5455-6465-7475+
China - Hong Kong SAR 1996-200179643925.331.735725.030.4359213727925346.753.129.930.421.4
China - Qidong 1992-20001377210.714.1657.68.4191237521721.40.00.010.714.3
China - Shangai 1992-199523013619.823.19419.121.2133063893539.038.025.916.38.6
China - Tianjin 1991-199921714331.936.27457.663.9313261732037.448.949.346.152.5
India - Karunagappally 1991-199728161218.822.4358930.00.00.014.20.0
Singapore 1993-19971598220.222.97714.115.7112937424045.949.620.31.73.9
Republic of Korea - Busan 1996-200118210010.311.48212.313.3103568581127.618.315.55.70.0
Republic of Korea - Incheon 1997-2001894812.314.34137.340.7102128191132.328.237.719.921.8
Republic of Korea - Seoul 1993-199734719624.728.015131.032.73971111953156.727.130.127.47.6
Thailand - Songkhla 1990-1999543033.935.92416.817.28141315431.624.249.215.20.0
Turkey - Izmir 1995-1997794126.030.43831.534.69222520314.039.734.427.354.3



Graphs:


Other tables available:

- Table 1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site
- Table 2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site
- Table 2b: Number and proportion of cases by vital status and median follow-up (in months) by site
- Table 3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site
- Table 4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group
- Table 5b: Proportion (%) of cases and 5-year absolute survival by extent of disease and site
- Table 6: Comparison of 5-year absolute and relative survival of cases diagnosed
- Table 7b: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 8: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 9: Up-to-date 10- and 15-year relative survival estimates using cohort and period approaches by site and calendar period